rethinkTHC Search
Menu
Study breakdown

Peri-pregnancy cannabis use was not linked to autism in offspring

Case ControlModerate evidence
The takeaway

Maternal cannabis use from 3 months before conception through delivery was not significantly associated with autism spectrum disorder in children, compared to population controls or children with other developmental conditions.

Parents, clinicians, and researchers interested in prenatal cannabis exposure and child development.

No significant difference in ASD rates by peri-pregnancy cannabis exposure

What the researchers found

Among children assessed at 30-68 months of age, peri-pregnancy cannabis use was reported for 5.2% of ASD cases, 3.2% of children with other developmental delays, and 4.4% of population controls. After adjustment, the odds of peri-pregnancy cannabis use did not differ significantly between groups.

Why it matters

Animal models and neurobiology have suggested potential risks of prenatal cannabis exposure for neurodevelopment, but this large study found no association with ASD in humans.

The numbers in context

4,254 children total. ASD: 5.2% cannabis exposed. Other developmental delays: 3.2% exposed. Population controls: 4.4% exposed. No significant differences between groups.

How the study worked

Case-control study comparing children with ASD (N=1,428), other developmental delays (N=1,198), and population controls (N=1,628) born 2003-2011 from the Study to Explore Early Development. Self-reported maternal cannabis use assessed for the period from 3 months pre-conception through delivery.

What this study cannot tell us

Self-reported cannabis use likely underestimates true exposure. Birth cohort (2003-2011) predates major legalization and potency increases. Cannot assess dose-response relationships.

How to read the evidence

Large multi-site case-control study with appropriate controls, though self-reported exposure and older birth cohort limit conclusions.

When this study was published

Published in 2022 with children born 2003-2011.

The bigger picture

While this study found no ASD link, the authors note that cannabis use patterns and perceptions have changed since the 2003-2011 birth cohort, making continued monitoring important.

Questions still open

  • Would results differ in more recent cohorts with higher potency cannabis and greater use prevalence? Could timing of exposure during pregnancy matter more than any/no exposure?

Common questions

Does this mean cannabis is safe during pregnancy?
This study only looked at ASD specifically and found no association. It does not address other potential risks of prenatal cannabis exposure, and the authors recommend further studies with more recent cohorts.
How many children were studied?
The study included 4,254 children: 1,428 with ASD, 1,198 with other developmental conditions, and 1,628 population controls.

Read the original research

Peri-Pregnancy Cannabis Use and Autism Spectrum Disorder in the Offspring: Findings from the Study to Explore Early Development.

Journal of autism and developmental disorders, 52(11), 5064-5071

Citation

DiGuiseppi, Carolyn; Crume, Tessa; Van Dyke, Julia; Sabourin, Katherine R; Soke, Gnakub N; Croen, Lisa A; Daniels, Julie L; Lee, Li-Ching; Schieve, Laura A; Windham, Gayle C; Friedman, Sandra; Robinson Rosenberg, Cordelia. (2022). Peri-Pregnancy Cannabis Use and Autism Spectrum Disorder in the Offspring: Findings from the Study to Explore Early Development.. Journal of autism and developmental disorders, 52(11), 5064-5071. https://doi.org/10.1007/s10803-021-05339-4

Explore the wider topic